Association of Peroxisome Proliferator-Activated Receptor γ Polymorphisms and Haplotypes with Essential Hypertension
Authors:
- 1 May 2013
- journal article
- research article
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 17 (5) , 418-423
Abstract
Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear receptor involved in the regulation of several biochemical pathways. Blood pressure-lowering effects have been found in PPARγ agonists in several hypertensive models. The biology and research data related to the gene suggest that it could play a role in essential hypertension (EH) susceptibility. This study aimed to investigate the association between PPARγ polymorphisms and EH. About 820 subjects were genotyped for the three single-nucleotide polymorphisms used as genetic markers for the PPARγ genes (C681G, Prol2Ala, and C1431T). After correction for age, sex, smoking, alcohol consumption, body mass index, waist circumference, and fasting glucose, the G allele (CG+GG) of C681G was significantly associated with the increase in the risk of EH (odds ratio [OR]=1.54, 95%confidence interval [CI]: 1.14–2.09, p=0.005). The A allele (PA+PP) of Pro12Ala was significantly associated with the decrease in the risk of EH (OR=0.70, 95%CI: 0.52–0.95, p=0.020). However, C1431T was not significantly associated with EH. Generalized multifactor dimensionality reduction analysis showed that there was a potential gene–gene interaction between C681G and Prol2Ala (p=0.0107). The G-P haplotype (established by C681G, Prol2Ala) was significantly associated with increase in the risk of EH (OR=1.53, 95%CI:1.13–2.07, p=0.006). In conclusion, PPARγ polymorphisms and haplotypes were significantly associated with hypertension susceptibility.Keywords
This publication has 16 references indexed in Scilit:
- Integration of metabolism and inflammation by lipid-activated nuclear receptorsNature, 2008
- Shaking the tree: mapping complex disease genes with linkage disequilibriumThe Lancet, 2005
- Long-term effects of the PPARγ activator pioglitazone on cardiac inflammation in stroke-prone spontaneously hypertensive ratsCanadian Journal of Physiology and Pharmacology, 2004
- A Functional Polymorphism in a STAT5B Site of the Human PPARγ3 Gene Promoter Affects Height and Lipid Metabolism in a French PopulationArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Effect of Peroxisome Proliferator–Activated Receptor-α and -γ Activators on Vascular Remodeling in Endothelin-Dependent HypertensionArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transportProceedings of the National Academy of Sciences, 2001
- The Peroxisome Poliferator–Activated Receptor-γ2 Pro12Ala VariantDiabetes, 2001
- A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humansHuman Molecular Genetics, 1998
- Terminal Differentiation of Human Breast Cancer through PPARγMolecular Cell, 1998
- Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension.Hypertension, 1994